Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells

被引:120
作者
Park, IH
Yeon, I
Youn, JH
Choi, JE
Sasaki, N
Choi, IH
Shin, JS
机构
[1] Yonsei Univ, Coll Med, Dept Microbiol, Project Med Sci, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Brain Korea 21, Project Med Sci, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 120752, South Korea
[4] Seoul Natl Univ, Borame Hosp, Dept Pediat, Seoul 156707, South Korea
[5] Sapporo Med Univ, Dept Neuropsychiat, Sapporo, Hokkaido 0608543, Japan
关键词
receptor for advanced glycation end products (RAGE); splice; astrocyte; peripheral blood mononuclear cells;
D O I
10.1016/j.molimm.2003.11.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The engagement of the receptor for advanced glycation end products (RAGE) on the cell surface induces cellular dysfunction in a number of pathophysiological situations of vascular dysfunction, tumor cell invasion, inflammatory response, and T cell infiltration. The administration of truncated, soluble RAGE can modulate RAGE-mediated perturbations. Here, we report a novel splice variant (Delta(8)-RAGE) of RAGE mRNA, which lacks exon 8 of the genomic RAGE gene and contains an early stop codon in exon 10 due to a frame shift mutation. Delta(8)-RAGE mRNA was found in human primary astrocytes and peripheral blood mononuclear cells (PBMCs). Transient transfection experiments demonstrated that Delta(8)-RAGE mRNA was translated into a secretory protein as deduced. Moreover, two different segments of the spliced variant were identified in PBMCs by RT-PCR. The findings of this study suggest that the diverse splicing variants of RAGE are possible in many tissues and their products may influence the RAGE-mediated pathogenesis and immune modulation. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1203 / 1211
页数:9
相关论文
共 27 条
[1]   Splicing in the inner ear: a familiar tune, but what are the instruments? [J].
Black, DL .
NEURON, 1998, 20 (02) :165-168
[2]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[3]   Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation [J].
Brink, R ;
Lodish, HF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :4129-4134
[4]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[5]  
CASCINO I, 1995, J IMMUNOL, V154, P2706
[6]  
Choi C, 1999, J IMMUNOL, V162, P1889
[7]  
DEANE R, 2003, NAT MED
[8]   Alternative splicing: increasing diversity in the proteomic world [J].
Graveley, BR .
TRENDS IN GENETICS, 2001, 17 (02) :100-107
[9]   Alternative splicing of human genes -: more the rule than the exception? [J].
Hanke, J ;
Brett, D ;
Zastrow, I ;
Aydin, A ;
Delbrück, S ;
Lehmann, G ;
Luft, F ;
Reich, J ;
Bork, P .
TRENDS IN GENETICS, 1999, 15 (10) :389-390
[10]   Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation [J].
Bowman, M. A. Hofmann ;
Heydemann, A. ;
Gawdzik, J. ;
Shilling, R. A. ;
Camoretti-Mercado, B. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (06) :878-889